99 related articles for article (PubMed ID: 11989255)
21. Larynx preservation and survival trends: should there be concern?
Forastiere AA
Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631
[No Abstract] [Full Text] [Related]
22. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
[No Abstract] [Full Text] [Related]
23. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
von Lilienfeld-Toal M; Glasmacher A
Cancer; 2005 Feb; 103(4):874; discussion 875. PubMed ID: 15611970
[No Abstract] [Full Text] [Related]
24. [Hematologic tumors].
Ogawa M
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
Miyazaki Y
Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
[No Abstract] [Full Text] [Related]
26. Commentary: induction chemotherapy for head and neck cancer: hypothesis-based rather than evidence-based medicine.
Eisbruch A
Oncologist; 2007 Aug; 12(8):975-7. PubMed ID: 17766657
[No Abstract] [Full Text] [Related]
27. [Preliminary study on alternative half body irradiation in the treatment of hematological malignancies].
Wei JL; Wang M; Zou DH; Yang DL; Li R; Ning J; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):355-8. PubMed ID: 15308016
[TBL] [Abstract][Full Text] [Related]
28. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
30. Drug Resistance in Hematological Malignancies.
Auberger P; Tamburini-Bonnefoy J; Puissant A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847013
[TBL] [Abstract][Full Text] [Related]
31. Reduced-intensity conditioning regimens in malignant haematological diseases.
Buffart TE; Janssen JJ; Huijgens PC
Neth J Med; 2005 Feb; 63(2):43-51. PubMed ID: 15766008
[TBL] [Abstract][Full Text] [Related]
32. Non-melanoma and non-renal cell carcinoma malignancies treated with interleukin-2.
Krastev Z; Koltchakov V; Tomov B; Koten JW
Hepatogastroenterology; 2003; 50(52):1006-16. PubMed ID: 12845968
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based alternative medicine?
Borgerson K
Perspect Biol Med; 2005; 48(4):502-15. PubMed ID: 16227663
[TBL] [Abstract][Full Text] [Related]
34. [Clinical experimental research in hematology: planning, data management and the presentation of the results].
Kulikov SM; Savchenko VG; Maslova ER; Parovichnikova EN; Gudulina IuIu
Ter Arkh; 1996; 68(7):65-72. PubMed ID: 8928076
[No Abstract] [Full Text] [Related]
35. Randomized clinical trials, clinical use, and hope: what relationship?
Rettig RA; Jacobson PD; Farquhar CM; Aubry WM
J Clin Oncol; 2008 May; 26(13):2223-4. PubMed ID: 18445852
[No Abstract] [Full Text] [Related]
36. Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation.
Mauro E; Rigolin GM; Fraulini C; Sofritti O; Ciccone M; De Angeli C; Castoldi G; Cuneo A
Eur J Haematol; 2007 May; 78(5):374-80. PubMed ID: 17331127
[TBL] [Abstract][Full Text] [Related]
37. [Evidence-based medicine in oncology: do the results of trials reflect clinical reality?].
Hölzel D; Schubert-Fritschle G
Zentralbl Chir; 2008 Feb; 133(1):15-9. PubMed ID: 18278696
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of transplantation material based on immunophenotype and in vitro clonogenic assays of hematopoietic stem and progenitor cells].
Balana-Nowak A; Zdziłowska E; Szostek M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():28-33. PubMed ID: 10494179
[TBL] [Abstract][Full Text] [Related]
39. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
McCulloch M; See C; Shu XJ; Broffman M; Kramer A; Fan WY; Gao J; Lieb W; Shieh K; Colford JM
J Clin Oncol; 2006 Jan; 24(3):419-30. PubMed ID: 16421421
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in clinical cancer trials.
Estey E
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2591-3. PubMed ID: 9815662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
